Lymphatic endothelial cells promote melanoma to spread

May 01, 2018

Despite the declining death rates for many individual cancer types, mortality for a few cancers has stabilized or even increased. One of these is melanoma due to its ability, in later stages, to spread to other parts of the body. Melanoma is considered metastatic - also called Stage IV melanoma - when the cancer cells have spread through the lymph nodes to distant sites in the body, the most often affected being liver, lungs, bones and brain.

Often primary melanomas grow and spread horizontally on the top layer of the skin before penetrating deeper into the layers of the dermis where they can reach the lymph and blood vessels. Lymphatic invasion and lymph node metastasis correlate with poor clinical outcome in melanoma.

In addition to providing a direct route for dissemination, the lymph vessels have been proposed to directly modulate the metastatic process through mechanisms that have remained elusive.

"Because the mechanisms and functional contribution of lymphatic dissemination in distant organ melanoma metastasis remain incompletely understood, we have investigated the contribution of the cells that form the walls of the lymphatic vessels, the lymphatic endothelial cells, to human melanoma cell invasion and metastasis", tells Professor Päivi Ojala from the University of Helsinki, Finland. She continues:

"In particular, our goal was to uncover the critical factors in the tumor lymphatic microenvironment that promote the melanoma cell distant organ metastasis and thereby to generate new leads and potential targets to more efficient treatments and prognosis for metastatic cancer."

Growing human melanoma cells in co-cultures with human primary lymphatic endothelial cells increased the invasive growth of melanoma cells in cell culture conditions that mimick the tissue environment and facilitated melanoma distant organ metastasis in mice implanted with human melanoma cells. This lymphatic endothelium mediated change in the melanoma was dependent on MMP14, Notch3 and ?1-integrin proteins, and MMP14 and Notch3 were necessary for the increased metastasis of human melanoma cells in a zebrafish tumor model.

The study uncovers a unique mechanism whereby the direct contact with lymphatic endothelial cells promotes melanoma metastasis.

"These findings can represent new leads that clinicians can consider as prognostic markers for metastasis and the pharmaceutical industry can pursue for further therapeutics development", Professor Ojala says.
-end-


University of Helsinki

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.